Concerns Surrounding Sangamo Therapeutics and Recent Developments
The Law Offices of Frank R. Cruz have initiated an investigation into Sangamo Therapeutics, Inc. (SGMO) to help investors who may have faced financial loss. Recent announcements have raised questions about the company's compliance with federal securities laws, prompting action from concerned stakeholders.
Why Are Investors Worried?
On December 30, a significant announcement from Sangamo caught the market's eye. The company revealed that it had received notification from Pfizer Inc. regarding the termination of their partnership concerning a gene therapy candidate aimed at treating hemophilia A. This unexpected news raised alarms among investors who had high hopes for this collaboration.
Impact of the Partnership Termination on Stock Prices
The announcement triggered a sharp decline in Sangamo's stock price, which plummeted by $1.32 or 56.4%. This dramatic drop left the shares closing at $1.02 on the following day. The severity of this decline underscores the market's adverse reaction to the discontinuation of such a pivotal partnership.
Understanding Investor Rights and Options
For investors affected by this downturn in stock prices, it's essential to understand what options may be available to them. If you purchased shares of Sangamo or have pertinent information regarding this situation, reaching out to legal authorities could be beneficial. The Law Offices of Frank R. Cruz are prepared to assist those interested in exploring their rights and potentially pursuing claims for reimbursement of losses.
Participating in the Investigation
The Law Offices of Frank R. Cruz underscore the importance of gathering information to advocate for investors. Engagement in this investigation is crucial for any shareholder wanting to learn more about possible actions they can take. If you have further questions or wish to provide relevant details about your investment, it’s encouraged to make direct contact.
Getting In Touch
If you're an investor with inquiries or wish to share your experience, contacting the Law Offices of Frank R. Cruz is straightforward. Located at 2121 Avenue of the Stars, Suite 800, Century City, California, their team is available to offer assistance.
Summary of Current Situation for Stockholders
The recent troubles faced by Sangamo Therapeutics have spotlighted the risks that investors encounter within the pharmaceutical industry. The uncertainty surrounding public companies, especially those undergoing changes in partnerships, can lead to significant volatility in stock value. Investors should stay informed of company developments and be vigilant regarding their investment rights.
Frequently Asked Questions
What caused the stock price drop for Sangamo Therapeutics?
The stock price plummeted after Sangamo announced the termination of its partnership with Pfizer for a hemophilia A gene therapy candidate.
Who can I contact for legal assistance regarding my investment?
The Law Offices of Frank R. Cruz are currently investigating the situation and can provide support to affected investors.
What are my options if I have lost money on Sangamo stock?
If you lost money, you may inquire about pursuing a claim to recover your losses through legal assistance.
How significant was the decline in stock value?
Sangamo's stock fell by $1.32, equivalent to 56.4%, following the unfavorable announcement.
Where is the Law Offices of Frank R. Cruz located?
They are located at 2121 Avenue of the Stars, Suite 800, Century City, California 90067.
